NCT07343856Enrolling by invitation
Long COVID Diagnostic Reactivity Assesment Test
Development of a Personalized Alternative Non-invasive Rapid Diagnostic Test for SARS-CoV-2 in Patients With Long COVID
Source: ClinicalTrials.gov · Last updated 15 Jan 2026
Brief summary (registry, in English)
This study is a diagnostic clinical investigation designed to evaluate bioelectrical response patterns assessed by electro-acupuncture-based medicament testing. The method is used to identify individual bioelectrical reactivity associated with the presence and persistence of pathological factors and to assess patient-specific responses to tested medicinal substances. The study involves a single-session, non-invasive diagnostic procedure without administration of pharmacological treatment. The primary objective is the methodological evaluation of the diagnostic approach and the characterization of the detected bioelectrical response patterns in the studied population.
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- First submitted
- 24 Dec 2025
- Start date
- 5 Dec 2025
- Primary completion date
- 30 Dec 2026
- Lead sponsor
- Oncology Center,Ministry Of Heath,Uzbekistan
- Diseases
- Long COVID and ME/CFS
- NCT number
- NCT07343856
What you commit to
- Study type: Interventional
- Planned participants: 50
- From 5 Dec 2025 to the primary completion date, 30 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Acute infectious disease at the time of enrollment
- Severe uncontrolled medical or psychiatric conditions that may interfere with diagnostic assessment
Other
- Implanted electronic medical devices (e.g., pacemaker)
- Pregnancy or breastfeeding
- Inability to comply with study procedures
Who the study is looking for
- Age 18 years or older
- History of confirmed SARS-CoV-2 infection
- Persistent symptoms consistent with Long COVID lasting ≥12 weeks after acute infection
- Ability to provide informed consent
- Willingness to undergo non-invasive bioelectrical diagnostic assessment
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Research Institute of Virology Coordinator of this site? Confirm its status | Tashkent | Uzbekistan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.